Testicular Cancer

Testicular cancer starts in the cells of the testicle (usually germ cells). It’s uncommon, but it’s the most frequent cancer in males ages 15–35 and can occur at any age. There is no routine screening recommended for people without symptoms; major groups advise against screening with a doctor exam or testicular self-exam in asymptomatic males. Most cases are found when someone notices a new, painless lump or swelling and sees a clinician. Diagnosis relies on scrotal ultrasound and blood tumor markers (AFP, β-hCG, LDH) interpreted with imaging and exam.


Signs & Situations (When to consider testing)

See a clinician promptly if you notice any of the following on one side:

  • A new lump, swelling, or firmness in the testicle (often painless)

  • A heavy feeling or a dull ache in the lower belly or groin

  • Breast tenderness or growth (from hormones some tumors make)

  • Back pain, shortness of breath, or belly swelling (possible advanced signs)

Emergency: sudden, severe testicular pain can be torsion, not cancer—get urgent care. Ultrasound is the first test for an acute scrotum. 

Risk factors: an undescended testicle (cryptorchidism)family or personal history of testicular cancer. Most people with these risks still do not develop cancer, but they should seek care quickly for new changes.


Why These Tests Matter

What testing can do

  • Ultrasound of the scrotum can tell if a lump is inside the testicle and if it looks like a tumor.

  • Tumor markers (AFP, β-hCG, LDH) help classify, stage, and monitor testicular cancer; they’re checked beforeand after surgery and during follow-up. 

What testing cannot do

  • Tumor markers cannot screen people without symptoms, and normal markers do not rule out cancer if imaging is suspicious. A biopsy is not done through the scrotum; instead, doctors often remove the affected testicle (orchiectomy) to confirm the diagnosis.


What These Tests Measure (at a glance)

  • AFP (alpha-fetoprotein): often high in nonseminomaseminomas do not make AFP.

  • β-hCG (human chorionic gonadotropin): can rise in both seminoma and nonseminoma.

  • LDH (lactate dehydrogenase): less specific, but can reflect tumor burden.

  • Scrotal ultrasound: first-line imaging for a testicular mass or acute pain.

  • Staging imaging (ordered by your clinician): CT of chest/abdomen/pelvis; markers help place you in risk groupswith treatment teams. 


How the Testing Process Works

  1. Clinical check & ultrasound: If you report a new lump or swelling, your clinician examines you and orders a scrotal ultrasound

  2. Blood tests: AFP, β-hCG, LDH are drawn—ideally before any surgery—to guide staging and later comparison.

  3. Confirming the diagnosis: If cancer is likely, the usual next step is orchiectomy (surgical removal of the testicle) for diagnosis and local control, followed by staging. 

  4. Ongoing monitoring: Tumor markers are repeated on a schedule during follow-up to check response and watch for recurrence.


Interpreting Results (general guidance)

  • High AFP and/or β-hCG support a germ cell tumor; patterns help separate seminoma from nonseminomaLDHadds context about tumor burden. 

  • Normal markers do not exclude cancer; ultrasound findings and pathology guide decisions. 

  • After surgery, falling markers are expected; rising or persistent markers may suggest remaining disease and prompt further evaluation (oncologist-directed). 

All test results should be reviewed with a urology or oncology professional.


Choosing Panels vs. Individual Tests

  • Suspicious lump or swelling: Scrotal ultrasound + AFP, β-hCG, LDH (drawn before surgery) are standard first steps. 

  • Monitoring after treatment (clinician-directed): repeat AFP, β-hCG, LDH at set intervals, plus imaging as needed.

  • General screening: Not recommended for people without symptoms; focus on awareness and prompt care for new changes.


FAQs

Do I need routine screening or self-exam?
Major groups recommend against routine screening in people without symptoms. Still, if you notice a change, get it checked.

Are blood tests enough to find testicular cancer?
No. Tumor markers help, but ultrasound and surgical pathology confirm the diagnosis. 

What age is most at risk?
It’s most common in ages 15–35, but it can occur earlier or later. Undescended testicle and family history raise risk. 

Is sudden severe testicle pain a sign of cancer?
Usually not. It could be torsion, which is an emergency. Get care right away. Ultrasound is typically the first test. 


Internal Links & Cross-References

  • Upward: Cancer Screening Hub

  • Sideways: Men’s Cancer & Tumor Markers • Prostate Cancer • Multi-Cancer Early Detection (MCED)

  • Downward (individual test pages): AFP • β-hCG • LDH • Scrotal Ultrasound (Clinical Imaging) • CT Chest/Abdomen/Pelvis (Clinical Imaging)


References

  1. U.S. Preventive Services Task Force. Testicular Cancer: Screening. Final Recommendation—Do not screen asymptomatic males. 2011.

  2. National Cancer Institute (PDQ). Testicular Cancer Screening—Patient/Health Professional Summaries. Updated 2025.

  3. American Urological Association (AUA). Diagnosis and Treatment of Early-Stage Testicular Cancer—Guideline and 2024 amendment; tumor markers (AFP, β-hCG, LDH) obtained before orchiectomy and for staging/monitoring.

  4. American Cancer Society. Tests for Testicular Cancer; tumor marker use before/after treatment and during follow-up. Updated 2025.

  5. American College of Radiology (ACR) Appropriateness Criteria. Acute Onset of Scrotal Pain—Ultrasound as first-line imaging. 2019–2025 practice updates.

  6. NCCN Guidelines (Professional/Patient). Testicular Cancer—serum markers in diagnosis/staging; marker assessment before and after orchiectomy. 2019–2025.


Available Tests & Panels

Tip: For a new testicular lump or swelling, clinicians start with scrotal ultrasound and AFP, β-hCG, LDH drawn before any surgery. Use markers later to monitor under oncology care.

 

  • Page
  • 1
  • of
  • 1
  • Total Rows
  • 7
Name Matches

The Alpha Fetoprotein (AFP) Tumor Marker Test measures AFP levels in blood to help detect and monitor cancers such as liver cancer, testicular cancer, and certain ovarian tumors. Elevated AFP may also be seen with liver disease, cirrhosis, or hepatitis. Doctors order this test for patients at risk of or being treated for cancer. Results provide essential insight for diagnosis, monitoring treatment response, and tracking cancer recurrence or progression.

Blood
Blood Draw
Also Known As: Alpha-Fetoprotein Test, AFP Tumor Marker Test

The Alpha-Fetoprotein (AFP) and AFP-L3 Test measures total AFP and the AFP-L3 fraction, which is more specific for liver cancer risk. Elevated AFP may indicate liver disease, germ cell tumors, or hepatitis, while AFP-L3 is strongly associated with hepatocellular carcinoma (HCC). Doctors order this test to assess liver function, screen high-risk patients, and monitor cancer treatment. Results provide critical insight into liver health and cancer detection.

Blood
Blood Draw
Also Known As: AFP Test, Total AFP Test, Alpha-Fetoprotein Tumor Markers, Alpha-Fetoprotein Test

The hCG Qualitative Urine Test detects human chorionic gonadotropin in urine to confirm pregnancy. It provides a simple positive or negative result, making it similar to an at-home pregnancy test but performed in a clinical setting for greater accuracy. Doctors order this test to evaluate missed periods, early pregnancy symptoms, or before medical procedures.

Urine
Urine Collection
Also Known As: Pregnancy Urine Test, Urine hCG Test, Qualitative Human Chorionic Gonadotropin

The hCG Total Qualitative Test detects the presence of human chorionic gonadotropin in blood to confirm pregnancy. Unlike the quantitative test, it provides a simple positive or negative result rather than exact levels. Doctors use this test to confirm suspected pregnancy, evaluate early symptoms, or screen before medical procedures.

Blood
Blood Draw
Also Known As:

Pregnancy Blood Test, Beta hCG Test, Qualitative Human Chorionic Gonadotropin


The hCG Total Quantitative Test measures human chorionic gonadotropin levels in blood to confirm pregnancy and monitor its progression. It provides exact hCG values, helping detect ectopic pregnancy, miscarriage risk, and abnormal growths like trophoblastic disease. Doctors also use it to track fertility treatments and evaluate certain cancers. This test offers precise insight into pregnancy health, reproductive function, and overall hormone balance.

Blood
Blood Draw
Also Known As: Beta hCG Test, Quantitative Chorionic Gonadotropin Test


Blood
Blood Draw, Phlebotomist

Testicular cancer is a rare form of cancer (the abnormal, uncontrolled growth of cells) that occurs in the testicles. Typically, males have two testicles, which are part of the reproductive system. Also referred to as gonads, these egg-shaped glands are held in a sac known as scrotum just below the penis. They have a slightly spongy feel, with uniform firmness and similar size. Testicles are responsible for sperm production and ideally make hormones like testosterone, which controls sex drive and starts the growth of muscles and body hair in males.

Testicular cancer can affect any boy or man of any age, but it usually affects those between the age of 20 and 35, and the average diagnosis age is 33. According to the American Cancer Society, around 9,000 men are diagnosed with the condition in the US each year, and about 4% of the patients die of it.

Fortunately, testicular cancer is treatable, and it’s one of the most curable forms of cancer. It has a five-year relative survival rate of 99% if it hasn’t spread beyond the testicles. However, if left unattended, it can spread to nearby organs, affecting the lymph nodes and even making its way to vital organs like lungs. The survival rate for regional cancer (one that has spread to nearby tissues or lymph nodes) is 96%, and that of distant cancer (spread to other organs) is 73%. When it comes to curing testicular cancer, early detection and treatment are vital.

Testicular Cancer Risk Factors Include:

  • Gonadal dysgenesis- the abnormal development of testicles
  • Prior cancer in one gonad
  • Cryptorchidism or undescended testicles.
  • History of a father or brother with testicular cancer
  • Abnormal cells in the testicles known as germ cell neoplasia in situ.
  • HIV infection
  • Stature- According to some studies, tall men have a higher risk of getting testicular cancer, but this hasn’t been proven.
  • Race- Caucasian men are at a higher risk for this type of cancer compared to Hispanic, African, and Asian males. However, the cause of this risk hasn’t been discovered.

Types of Testicular Tumors

  • Stromal Tumors: These types of tumors account for 5% of testicular tumors in adults and 20% in children. They form in the tissues that make hormones and support the testicles. They are usually non-cancerous, and the primary types include:
  • Leydig Cell Tumor: This type of tumor forms in the cells responsible for producing male sex hormones like testosterone. The tumor itself can produce male sex hormones and, sometimes, estrogen (a female sex hormone), which leads to breast enlargement.
  • Sertoli Cell Tumor: This one affects cells that support germ cells, which are responsible for sperm production.
  • Germ Cell Tumor: This one affects the cells that produce sperm. It accounts for over 90% of testicular cancers. These can be separated into two categories, seminomas, and nonseminomas. Some of these tumors have both seminoma and nonseminomas tissues. The former type is less aggressive, meaning they develop slowly are less likely to metastasize or spread to other tissues or organs. They come two types, typical or classical (which make up around 95% of seminomas) and spermatocytic, which are rare and tend to affect older males. Nonseminomas or non-seminomatous germ cell tumors come in four types. These include teratomas, yolk sac tumors, choriocarcinomas, and embryonal carcinomas. These tend to spread faster than seminomas and usually affect younger men.

Some other forms of cancer, like lymphoma, can spread from other tissues and organs to the testicles, but they are not considered true testicular cancers as they are treated differently.

Signs & Symptoms

Often, testicular cancer is initially detected as a painless swelling or lump in the testicle. Affected individuals usually discover these tumors by accident or when examining themselves. However, they can ideally be discovered during a routine physical evaluation or a medical test that’s being conducted for other reasons like infertility evaluation.

Testicular cancer usually doesn’t give warning signs, but it may cause subtle symptoms like:

  • Dull pain in the groin or abdomen
  • Breast growth
  • Pain in the testicles
  • Early puberty with signs like body or facial growth and deepening of the voice

Keep in mind that these symptoms can be a result of other conditions like inflammation or injury and so, you should not be quick to conclude its cancer.

Early Testicular Cancer Detection

Currently, there are no means to screen for testicular cancer. Also, there are no studies that show if self-exams, regular evaluations by a practitioner, or other screening tests in males with no testicular cancer symptoms would reduce the risk of death from the condition.

Some doctors recommend individuals between 15 and 55 years to do a monthly self-evaluation to identify any changes in their gonads. Most, if not all, doctors agree that a testicular exam should be included in every general physical evaluation. The American Cancer Society (ACS) recommends the exam as part of cancer-related checkups, but it doesn’t have recommendations for testicular self-exams. Those who are at a higher risk for the condition may want to do a self-exam once per month.

Testicular Cancer Lab Tests

Various tests can be done to check for testicular cancer. These are primarily blood tests that look for elevated amounts of the proteins discussed below:

Alpha-fetoprotein (AFP)

Nonseminoma germ cells usually produce AFP. Seminoma germ cell tumors, on the other hand, don’t. So, if an individual’s AFP levels are high, the doctor will know that their tumor is composed of nonseminoma cells, and the cancer should be treated as such.

Human Chorionic Gonadotropin (hCG)

Both seminomas and nonseminomas (non-seminomatous germ cell tumors) can lead to the elevation of hCG levels in the blood.

Keep in mind that Sertoli and Leydig cell tumors (going under the umbrella term Stromal tumors) don’t produce hCG or AFP, and so, they won’t lead to the increase in blood levels of each.

Lactate dehydrogenase (LDH)

The levels of this protein can go up in the presence of most testicular cancer types. LDH is a type of enzyme present in many body tissues and makes its way into the bloodstream when a cell is damaged. However, it’s not specific for this type of cancer, as many conditions can cause LDH levels to rise. If an individual has testicular cancer, high LDH levels can be a sign that it is widespread.

Testicular ultrasound can also be conducted to check for suspicious lumps. X-rays can also be done to check whether the cancer has spread to lymph nodes and other vital organs.